These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 3973822

  • 41. NTP Toxicology and Carcinogenesis Studies of AZT (CAS No. 30516-87-1) and AZT/alpha-Interferon A/D B6C3F1 Mice (Gavage Studies).
    National Toxicology Program .
    Natl Toxicol Program Tech Rep Ser; 1999 Feb; 469():1-361. PubMed ID: 12579204
    [Abstract] [Full Text] [Related]

  • 42. [Biologically active hydroxamic acids--iron complexons].
    Kol'tsova GN, Mel'nikovskaia NN, Likhodzievskiĭ KG, Rozenberg GIa.
    Gematol Transfuziol; 1984 Sep; 29(9):56-9. PubMed ID: 6394425
    [No Abstract] [Full Text] [Related]

  • 43. Clinical management of thalassemia. The status of new iron chelators.
    Cerami A, Grady RW, Peterson CM, Bhargava KK.
    Ann N Y Acad Sci; 1980 Sep; 344():425-35. PubMed ID: 6446872
    [No Abstract] [Full Text] [Related]

  • 44. Polyhydroxamic microcapsules prepared from proteins: a novel type of chelating microcapsules.
    Hettler D, Andry MC, Levy MC.
    J Microencapsul; 1994 Sep; 11(2):213-24. PubMed ID: 8006768
    [Abstract] [Full Text] [Related]

  • 45. Syntheses of cyclic hydroxamic acid derivatives, and their chelating abilities and biological activities.
    Tanaka K, Matsuo K, Nakanishi A, Kataoka Y, Takase K, Otsuki S.
    Chem Pharm Bull (Tokyo); 1988 Jul; 36(7):2323-30. PubMed ID: 3240464
    [No Abstract] [Full Text] [Related]

  • 46. Syntheses of iron bis(pyridoxal isonicotinoylhydrazone)s and the in vivo iron-removal properties of some pyridoxal derivatives.
    Avramovici-Grisaru S, Sarel S, Link G, Hershko C.
    J Med Chem; 1983 Feb; 26(2):298-302. PubMed ID: 6827549
    [Abstract] [Full Text] [Related]

  • 47. Mugineic acid, active ingredient of wheat grass: an oral novel hexadentate iron chelator in iron overloaded diseases.
    Das P, Mukhopadhyay S, Kumar Sarkar N, Mandal S, Kar M, Mukhopadhyay A.
    J Biochem; 2016 Sep; 160(3):163-76. PubMed ID: 27008864
    [Abstract] [Full Text] [Related]

  • 48. Reactions of N-benzyloxycarbamate derivatives with stabilized carbon nucleophiles: a new synthetic approach to polyhydroxamic acids and other hydroxamate-containing mixed ligand systems.
    Liu Y, Jacobs HK, Gopalan AS.
    J Org Chem; 2009 Jan 16; 74(2):782-8. PubMed ID: 19063593
    [Abstract] [Full Text] [Related]

  • 49. Editorial: Symposium on iron poisoning.
    Angle CR.
    Clin Toxicol; 1971 Dec 16; 4(4):525-7. PubMed ID: 5164169
    [No Abstract] [Full Text] [Related]

  • 50. The effect of 2,4-dihydroxypyridine-N-oxide, a new orally active iron chelator, on iron excretion in mice.
    Kontoghiorghes GJ.
    Clin Chim Acta; 1987 Mar 16; 163(2):137-41. PubMed ID: 3568416
    [Abstract] [Full Text] [Related]

  • 51. Enhanced iron removal from liver parenchymal cells in experimental iron overload: liposome encapsulation of HBED and phenobarbital administration.
    Rahman YE, Cerny EA, Lau EH, Carnes BA.
    Blood; 1983 Jul 16; 62(1):209-13. PubMed ID: 6407548
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. DETERMINATION OF DESFERRIOXAMINE-BOUND IRON IN URINE.
    KAHN LB.
    S Afr Med J; 1964 Jul 04; 38():463-4. PubMed ID: 14179950
    [No Abstract] [Full Text] [Related]

  • 54. [Synthesis of polyphenolic aminocarboxylic acid derivatives as radio-actinides mobilization agents].
    Du J, Sun MZ, Xue F.
    Yao Xue Xue Bao; 1989 Jul 04; 24(9):711-4. PubMed ID: 2618722
    [Abstract] [Full Text] [Related]

  • 55. Aqueous mixture of pyrrolidone-5-hydroxamic acid-iron (III) complexes: isolation and characterization of tris (pyrrolidone-5-hydroxamato) iron (III).
    Pećar M, Kujundzić N, Mlinarević B, Cerina D, Horvat B, Verić M.
    J Pharm Sci; 1975 Jun 04; 64(6):970-3. PubMed ID: 1133753
    [Abstract] [Full Text] [Related]

  • 56. Complexation of labile metal ions and effect on toxicity.
    Martell AE.
    Biol Trace Elem Res; 1989 Jun 04; 21():295-303. PubMed ID: 2484602
    [Abstract] [Full Text] [Related]

  • 57. Exploiting the biosynthetic machinery of Streptomyces pilosus to engineer a water-soluble zirconium(iv) chelator.
    Richardson-Sanchez T, Tieu W, Gotsbacher MP, Telfer TJ, Codd R.
    Org Biomol Chem; 2017 Jul 21; 15(27):5719-5730. PubMed ID: 28650492
    [Abstract] [Full Text] [Related]

  • 58. Isolation and characterization of a new hydroxamic acid from Pseudomonas mildenbergii.
    Hulcher FH.
    Biochemistry; 1982 Aug 31; 21(18):4491-5. PubMed ID: 7126553
    [Abstract] [Full Text] [Related]

  • 59. Synthesis and pharmacological study of a polymer which selectively binds mercury.
    Harbison RD, Jones MM, MacDonald JS, Pratt TH, Coates RL.
    Toxicol Appl Pharmacol; 1977 Dec 31; 42(3):445-54. PubMed ID: 601789
    [No Abstract] [Full Text] [Related]

  • 60. [Polymeric catalysts in aqueous solution (author's transl)].
    Ise N.
    Tanpakushitsu Kakusan Koso; 1976 Dec 31; 21(7):583-90. PubMed ID: 135274
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.